Quick Answer
MAXCYTE, INC. reported Shares Outstanding of 106.79 million shares for fiscal year 2025.
MAXCYTE, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 106.79M | +1.0% |
| 2024 | 105.71M | +1.7% |
| 2023 | 103.96M | +1.5% |
| 2022 | 102.40M | +1.2% |
| 2021 | 101.20M | +30.8% |
| 2020 | 77.38M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 106.64M | +1.3% | +0.0% |
| June 30, 2025 | 106.59M | +1.7% | +0.3% |
| March 31, 2025 | 106.31M | +1.8% | +0.6% |
| December 31, 2024 | 105.71M | +1.7% | +0.4% |
| September 30, 2024 | 105.30M | +1.7% | +0.5% |
| June 30, 2024 | 104.82M | +1.6% | +0.4% |
| March 31, 2024 | 104.41M | +1.5% | +0.4% |
| December 31, 2023 | 103.96M | +1.5% | +0.4% |
- MAXCYTE, INC. showed an increase of +1.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, MAXCYTE, INC.’s shares outstanding has grown by 38.0% (from 77.38 million shares to 106.79 million shares).
- The most recent figure is from MAXCYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: